BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tong L, Ahn C, Symanski E, Lai D, Du XL. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer. Ann Oncol 2014;25:1234-42. [PMID: 24681607 DOI: 10.1093/annonc/mdu131] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lorimer PD, Motz BM, Kirks RC, Han Y, Symanowski JT, Hwang JJ, Salo JC, Hill JS. Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER‐Medicare. J Surg Oncol 2019;120:407-14. [DOI: 10.1002/jso.25508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Soares-miranda L, Abreu S, Ruiz-casado A, Lucia A. Physical activity and nutritional interventions and health-related quality of life in colorectal cancer survivors: a review. Expert Review of Quality of Life in Cancer Care 2018;3:95-104. [DOI: 10.1080/23809000.2018.1503538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Farrell C, Heaven C. Understanding the impact of chemotherapy on dignity for older people and their partners. European Journal of Oncology Nursing 2018;36:82-8. [DOI: 10.1016/j.ejon.2018.05.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Boakye D, Rillmann B, Walter V, Jansen L, Hoffmeister M, Brenner H. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: A systematic review and meta-analysis. Cancer Treatment Reviews 2018;64:30-9. [DOI: 10.1016/j.ctrv.2018.02.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
5 Lam CJK, Enewold L, McNeel TS, White DP, Warren JL, Mariotto AB. Estimating Chemotherapy Use Among Patients With a Prior Primary Cancer Diagnosis Using SEER-Medicare Data. J Natl Cancer Inst Monogr 2020;2020:14-21. [PMID: 32412067 DOI: 10.1093/jncimonographs/lgaa005] [Reference Citation Analysis]
6 Michalopoulou E, Matthes KL, Karavasiloglou N, Wanner M, Limam M, Korol D, Held L, Rohrmann S. Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: A population-based study. Cancer Epidemiol 2021;73:101962. [PMID: 34051687 DOI: 10.1016/j.canep.2021.101962] [Reference Citation Analysis]
7 Chen Y, Lairson DR, Chan W, Du XL. Risk of adverse events associated with front-line anti-myeloma treatment in Medicare patients with multiple myeloma. Ann Hematol 2018;97:851-63. [PMID: 29333596 DOI: 10.1007/s00277-018-3238-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Yamano T, Yamauchi S, Kimura K, Babaya A, Hamanaka M, Kobayashi M, Fukumoto M, Tsukamoto K, Noda M, Tomita N, Sugihara K, Takemasa I, Hakamada K, Kameyama H, Takii Y, Hase K, Kotake K, Watanabe T, Takahashi K, Kanemitsu Y, Itabashi M, Yano H, Yasuno M, Hasegawa H, Hashiguchi Y, Masaki T, Watanabe M, Maeda K, Komori K, Sakai Y, Ohue M, Akagi Y. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study. European Journal of Cancer 2017;81:90-101. [DOI: 10.1016/j.ejca.2017.05.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
9 Fogarassy G, Vathy-Fogarassy Á, Kenessey I, Kásler M, Forster T. Risk prediction model for long-term heart failure incidence after epirubicin chemotherapy for breast cancer - A real-world data-based, nationwide classification analysis. Int J Cardiol 2019;285:47-52. [PMID: 30905520 DOI: 10.1016/j.ijcard.2019.03.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Aoullay Z, Slaoui M, Razine R, Er-Raki A, Meddah B, Cherrah Y. Therapeutic Characteristics, Chemotherapy-Related Toxicities and Survivorship in Colorectal Cancer Patients. Ethiop J Health Sci 2020;30:65-74. [PMID: 32116434 DOI: 10.4314/ejhs.v30i1.9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 White A, Joseph D, Rim SH, Johnson CJ, Coleman MP, Allemani C. Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study. Cancer 2017;123 Suppl 24:5014-36. [PMID: 29205304 DOI: 10.1002/cncr.31076] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
12 Lee KY, Park JW, Lee KY, Cho S, Kwon YH, Kim MJ, Ryoo SB, Jeong SY, Park KJ. Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer. Sci Rep 2019;9:11846. [PMID: 31413354 DOI: 10.1038/s41598-019-48197-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lin J, Siegartel LR, Lingohr-smith M, Menges B, Makenbaeva D. Using Health Care Claims Data to Assess the Prevalence of Hodgkin Lymphoma and Relapsed or Refractory Hodgkin Lymphoma in the United States. Clinical Therapeutics 2017;39:303-10. [DOI: 10.1016/j.clinthera.2016.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
14 Hameed SA, Kusters IS, Khan M, Matz M. Colon cancer survival in California from 2004 to 2011 by stage at diagnosis, sex, race/ethnicity, and socioeconomic status. Cancer Epidemiol 2021;72:101901. [PMID: 33636581 DOI: 10.1016/j.canep.2021.101901] [Reference Citation Analysis]
15 Afifi AM, Elmehrath AO, Ruhban IA, Saad AM, Gad MM, Al-Husseini MJ, Bekaii-Saab T, Sonbol MB. Causes of Death Following Nonmetastatic Colorectal Cancer Diagnosis in the U.S.: A Population-Based Analysis. Oncologist 2021;26:733-9. [PMID: 34101294 DOI: 10.1002/onco.13854] [Reference Citation Analysis]
16 Joachim C, Godaert L, Dramé M, Véronique-Baudin J, Macni J, Smith-Ravin J, Novella JL, Mahmoudi R. Overall survival in elderly patients with colorectal cancer: A population-based study in the Caribbean. Cancer Epidemiol 2017;48:85-91. [PMID: 28426981 DOI: 10.1016/j.canep.2017.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Wu W, Wu F, Wang Z, Di J, Yang J, Gao P, Jiang B, Su X. CENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer. J Cancer 2017;8:2163-72. [PMID: 28819418 DOI: 10.7150/jca.19940] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
18 van Eeghen EE, Bakker SD, van Bochove A, Loffeld RJ. Impact of age and comorbidity on survival in colorectal cancer. J Gastrointest Oncol 2015;6:605-12. [PMID: 26697191 DOI: 10.3978/j.issn.2078-6891.2015.070] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
19 Lu L, Ma L, Zhang X, Susanne Mullins C, Linnebacher M. Analyzing non-cancer causes of death of colorectal carcinoma patients in the US population for the years 2000-2016. Cancer Med 2021;10:2740-51. [PMID: 33314795 DOI: 10.1002/cam4.3673] [Reference Citation Analysis]
20 Zhao X, Yang Y, Gu H, Zhou W, Zhang Q. New prognostic risk score for predicting in-hospital mortality in geriatric patients undergoing colorectal cancer surgery: U.S. Nationwide Inpatient Sample analysis. J Geriatr Oncol 2020;11:1250-4. [PMID: 32376233 DOI: 10.1016/j.jgo.2020.04.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Tong L, Ahn C, Symanski E, Lai D, Du XL. Relative impact of earlier diagnosis and improved treatment on survival for colorectal cancer: A US database study among elderly patients. Cancer Epidemiology 2014;38:733-40. [DOI: 10.1016/j.canep.2014.10.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]